Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latin American Countries To Coordinate Purchase Of Monkeypox Vaccine

Executive Summary

Member states of the Pan American Health Organization have approved a resolution to combine purchasing power to buy monkeypox vaccines.

You may also be interested in...



New Initiative Aims To Drive Local COVID-19 Vaccine Production in Latin America

Pharmaceutical companies have been invited to take part in technology transfer for vaccines.

R&D Industry Finds Biosimilar Interchangeability Statement By EU Regulators ‘Concerning’

A joint statement from the European Medicines Agency and Heads of Medicines Agencies on biosimilar interchangeability is “concerning,” says Europe’s R&D-based industry federation, EFPIA.

Slovakia Eases Market Access For Innovative Medicines

Slovakia has introduced a new system for agreeing managed entry agreements that will make it easier for companies to get their innovative medicines to the market.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS146844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel